Search

Your search keyword '"CTI Bont"' showing total 169 results

Search Constraints

Start Over You searched for: Author "CTI Bont" Remove constraint Author: "CTI Bont"
169 results on '"CTI Bont"'

Search Results

1. Clinical presentation and outcome of invasive mould disease in paediatric patients with acute lymphoblastic leukaemia

2. Substantial Burden of Nonmedically Attended RSV Infection in Healthy-Term Infants: An International Prospective Birth Cohort Study

3. Estimation of introduction and transmission rates of SARS-CoV-2 in a prospective household study

4. Disagreement FDA and EMA on RSV Maternal Vaccination: Possible Consequence for Global Mortality

5. Outpatient respiratory syncytial virus infections and novel preventive interventions

6. Airway and Blood Monocyte Transcriptomic Profiling Reveals an Antiviral Phenotype in Infants With Severe Respiratory Syncytial Virus Infection

7. External Validation of the Discriminative Validity of the ReSVinet Score and Development of Simplified ReSVinet Scores in Secondary Care

8. Incorporating data from multiple endpoints in the analysis of clinical trials: example from RSV vaccines

9. Validity of clinical severity scores for respiratory syncytial virus: a systematic review

10. Respiratory syncytial virus vaccination during pregnancy for improving infant outcomes

11. Daily intranasal palivizumab to prevent respiratory syncytial virus infection in healthy preterm infants: a phase 1/2b randomized placebo-controlled trial

13. Maternal vaccination against RSV can substantially reduce childhood mortality in low-income and middle-income countries: A mathematical modeling study

14. Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection

15. Highly multiplexed spatial analysis identifies tissue-resident memory T cells as drivers of ulcerative and immune checkpoint inhibitor colitis

16. Biobanking and consenting to research: a qualitative thematic analysis of young people’s perspectives in the North East of England

18. Adeno-associated virus 2 infection in children with non-A–E hepatitis

19. Lethal Respiratory Syncytial Virus in Zambia Is Sensitive to Long-acting Monoclonal Antibodies

21. Universal infant immunisation against respiratory syncytial virus and European inequalities: the pandemics lesson has not been learnt

22. Are maternal vaccines effective and safe for mothers and infants?: A systematic review and meta-analysis of randomised controlled trials

23. Incidence of Respiratory Syncytial Virus Infection in Older Adults: Limitations of Current Data

24. Respiratory syncytial virus infection and novel interventions

25. Genomic investigations of unexplained acute hepatitis in children

26. Multifocal motor neuropathy is not associated with altered innate immune responses to endotoxin

27. Year-Round Respiratory Syncytial Virus Transmission in The Netherlands Following the COVID-19 Pandemic: A Prospective Nationwide Observational and Modeling Study

28. Bacterial Colonization of the Lower Airways in Children With Esophageal Atresia

29. Identification of circulating monocytes as producers of tuberculosis disease biomarker C1q

30. Cost-effectiveness of monoclonal antibody and maternal immunization against respiratory syncytial virus (RSV) in infants: Evaluation for six European countries

31. RSV immunisation: lessons from the COVID-19 pandemic

33. Economic burden and health-related quality-of-life among infants with respiratory syncytial virus infection: A multi-country prospective cohort study in Europe

34. High dupilumab levels in tear fluid of atopic dermatitis patients with moderate-to-severe ocular surface disease

35. The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study

36. Nosocomial RSV-related In-hospital Mortality in Children <5 Years: A Global Case Series

37. Biomarkers in tear fluid of dupilumab-treated moderate-to-severe atopic dermatitis patients

38. Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data

40. Soluble Signal Inhibitory Receptor on Leukocytes-1 Is Released from Activated Neutrophils by Proteinase 3 Cleavage

41. Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape

42. Estimation of introduction and transmission rates of SARS-CoV-2 in a prospective household study

43. Immune Response following BNT162b2 mRNA COVID-19 Vaccination in Pediatric Cancer Patients

44. Differential isoform expression of Allergin-1 during acute and chronic inflammation

45. Longitudinal Household Assessment of Respiratory Illness in Children and Parents During the COVID-19 Pandemic

46. International changes in respiratory syncytial virus (RSV) epidemiology during the COVID-19 pandemic: Association with school closures

47. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis

49. Decreased Antibody Response After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Patients With Down Syndrome

50. Clinical and Viral Factors Associated With Disease Severity and Subsequent Wheezing in Infants With Respiratory Syncytial Virus Infection

Catalog

Books, media, physical & digital resources